What is Toxoplasma gondii?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Toxoplasma gondii?

Toxoplasma gondii is an obligate intracellular parasitic protozoan with worldwide distribution that infects approximately one-third of the human population and can cause devastating consequences for fetuses, immunocompromised patients, and occasionally immunocompetent individuals. 1

Organism Classification and Biology

  • T. gondii is an obligate intracellular parasite, meaning it can only survive and replicate inside host cells, not in extracellular environments. 1, 2

  • The parasite exists in multiple forms: rapidly dividing tachyzoites (acute infection stage), dormant bradyzoites within tissue cysts (chronic/latent stage), and oocysts (environmental stage shed by cats). 2

  • T. gondii infects a remarkably wide range of warm-blooded animals and birds, making it one of the most successful parasites globally. 1, 3

Transmission Routes

Humans acquire T. gondii primarily through three routes: ingestion of oocysts from cat feces-contaminated sources (accounting for ~78% of infections in pregnant women), consumption of tissue cysts in undercooked meat, or transplacental transmission from acutely infected mothers to fetuses. 1, 4

Primary transmission mechanisms include:

  • Oocyst ingestion from contaminated soil, water, unwashed produce, or contact with cat litter—this is the predominant route in the United States. 1

  • Tissue cyst consumption in undercooked or raw meat, particularly pork, lamb, venison, and locally produced cured/dried/smoked meats. 1

  • Congenital transmission occurs when pregnant women acquire acute primary infection, with transmission risk ranging from 2-6% in first trimester to 81% in late pregnancy (though early infection causes more severe fetal disease). 1

  • Rare routes include organ transplantation, blood transfusion, and laboratory accidents. 1

Critical food safety temperatures to kill tissue cysts:

  • Whole cut meat (excluding poultry): 63°C (145°F) 1, 4
  • Ground meat (excluding poultry): 71°C (160°F) 1, 4
  • All poultry: 74°C (165°F) 1, 4
  • Freezing below -20°C (-4°F) for at least 48 hours also inactivates cysts 1

Microwave cooking is insufficient because it does not generate homogenous temperatures. 1

Clinical Significance and Disease Manifestations

In immunocompetent individuals:

  • 70-90% of acquired infections remain asymptomatic. 1, 5

  • When symptomatic, the most common presentation is cervical lymphadenopathy with a mononucleosis-like syndrome (fever, malaise, sore throat, myalgia). 1, 5

  • The infection is typically self-limited and benign in this population. 5

In congenitally infected infants:

  • 70-90% are asymptomatic at birth, but the majority develop late sequelae including retinitis, visual impairment, intellectual disability, and neurologic impairment over months to years if untreated. 1

  • Without maternal treatment, 85% develop vision impairment, 36% have recurrent eye disease, 27% have abnormal cognition, and 16% experience IQ decrease >15 points. 4

  • Symptomatic newborns may present with generalized disease (rash, lymphadenopathy, hepatosplenomegaly, jaundice, cytopenias) or predominantly neurologic disease (hydrocephalus, intracranial calcifications, microcephaly, chorioretinitis, seizures). 1

In immunocompromised patients:

  • Toxoplasma encephalitis is the primary concern, presenting with focal neurologic deficits, fever, altered consciousness, or seizures. 1, 5

  • This occurs from reactivation of latent tissue cysts when immunity becomes impaired (particularly CD4 <200 cells/mm³ in HIV patients). 1, 5

  • Less common manifestations include pneumonitis, myocarditis, and disseminated disease. 1

Epidemiology

  • The incidence of congenital toxoplasmosis in the United States is estimated at 1 per 1,000-12,000 live births and has decreased substantially over the past 20 years. 1, 5

  • Toxoplasma seropositivity among U.S. women is approximately 15%, with no difference between HIV-infected and uninfected women. 1

  • Approximately 50% of infected individuals have no conventional risk factors (no cat litter or raw meat exposure) and report no symptoms at the time of primary infection. 1, 4

Genetic Strains

  • Three main clonal lineages exist (Types 1,2, and 3) in North America and Europe, with Type 2 predominating in Western Europe. 1

  • All three types plus a fourth lineage (Type 12) are found in North America. 1

  • Atypical strains outside these lineages are frequently reported in the Americas and may have different virulence profiles. 1

Key Clinical Pitfalls

  • Do not rely on selective screening based on self-reported risk factors alone—this approach misses >50% of women who give birth to infants with congenital toxoplasmosis. 4

  • Cats are not the only or even primary source of infection—oocyst contamination of food, water, and soil accounts for most U.S. infections. 1, 4

  • Having ≥3 kittens in the household is a specific risk factor because young cats shed more oocysts. 1

  • Novel risk factors include eating raw oysters, clams, or mussels and drinking unpasteurized goat milk. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Mechanisms of Toxoplasma gondii persistence and latency.

FEMS microbiology reviews, 2012

Research

Communication between Toxoplasma gondii and its host: impact on parasite growth, development, immune evasion, and virulence.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2009

Guideline

Toxoplasmosis Prevention and Transmission Risks

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acquired Toxoplasmosis in Immunocompetent Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.